Performance Evaluation Of The Clinimacs System For The Positive Selection Of CD34+ Cells From Stem Cell Products Factors Affecting CD34+ Cell Recovery
CD34+ cell dose in the transplanted product is still considered a measure of the engraftment potential in haemopoietic stem cell transplantation (HSCT). CD34+ selected products are characterised by their high purity and depleted T-cells. These characteristics have made them traditionally suitable to...
Autor Principal: | Orjuela Falla, Guillermo Andrés |
---|---|
Formato: | Trabajo de grado (Bachelor Thesis) |
Lenguaje: | Desconocido (Unknown) |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | http://babel.banrepcultural.org/cdm/ref/collection/p17054coll23/id/379 |
Ejemplares similares
-
Transplant autologous “enhanced” stem cells CD34+ bone marrow in patients with refractory angina
por: Blanco, Margarita I., et al.
Publicado: (2016) -
Autophagy Proteins ATG5 and ATG7 Are Essential for the Maintenance of Human CD34(+) Hematopoietic Stem-Progenitor Cells
por: Gómez Puerto, María Catalina; Folkerts, H.; Wierenga, A. T.; Schepers, K.; Schuringa, J. J.; Coffer, Paul J.; Vellenga, E.
Publicado: (2016) -
Estudio bibliométrico: 45 años de literatura biomédica en trasplante de células madre hematopoyéticas
por: Ríos Moreno, Jenifer Vanessa, et al.
Publicado: (2020) -
Trasplante de células madres embrionarias. Implicaciones ético-legales
por: Santamaría Rodríguez, Gabriel, et al.
Publicado: (2020) -
Transplante autólogo potenciado de células madre CD34+ de mádula ósea, en pacientes con angina refractaria. Estudio Piloto
por: Inés Blanco, Margarita, et al.
Publicado: (7/7/)